Literature DB >> 19408043

The importance of distinguishing mucinous and nonmucinous bronchioloalveolar carcinomas.

David H Garfield, Jacques Cadranel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19408043     DOI： 10.1007/s00408-009-9149-3

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  7 in total

1.  let-7 microRNA expression and the distinction between nonmucinous and mucinous bronchioloalveolar carcinomas.

Authors:  David Garfield
Journal:  Lung Cancer       Date:  2008-04-18       Impact factor: 5.705

2.  Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.

Authors:  F Clayton
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

3.  Bronchioloalveolar carcinoma: The significance of two histopathologic types.

Authors:  J T Manning; H J Spjut; J A Tschen
Journal:  Cancer       Date:  1984-08-01       Impact factor: 6.860

Review 4.  Bronchioloalveolar carcinoma: the case for two diseases.

Authors:  David H Garfield; Jacques Cadranel; Howard L West
Journal:  Clin Lung Cancer       Date:  2008-01       Impact factor: 4.785

5.  IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype.

Authors:  Jacques Cadranel; Elisabeth Quoix; Laurence Baudrin; Pierre Mourlanette; Denis Moro-Sibilot; Jean-François Morere; Pierre-Jean Souquet; Jean-Charles Soria; Franck Morin; Bernard Milleron
Journal:  J Thorac Oncol       Date:  2009-09       Impact factor: 15.609

6.  Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.

Authors:  Marie Wislez; Martine Antoine; Laurence Baudrin; Virginie Poulot; Agnes Neuville; Maryvonne Pradere; Elisabeth Longchampt; Sylvie Isaac-Sibille; Marie-Paule Lebitasy; Jacques Cadranel
Journal:  Lung Cancer       Date:  2009-07-05       Impact factor: 5.705

7.  Expression of FAK and PTEN in bronchioloalveolar carcinoma and lung adenocarcinoma.

Authors:  Changli Wang; Ran Yang; Dongsheng Yue; Zhenfa Zhang
Journal:  Lung       Date:  2009-02-26       Impact factor: 2.584
  7 in total
  1 in total

Review 1.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.